|
Home | Medical-Newswire.Com:
|
 (Medical-NewsWire.com, October 27, 2016 ) The report "North American Drug Delivery Technologies Market by Route of Administration (Oral (Solid), Pulmonary (Nebulizer), Injectable (Device), Ocular (Device), Nasal (Drop), Topical (Solid), Implantable (Active)), End User (Hospital, Home Care) - Global...
Source: EmailWire.com
 (Medical-NewsWire.com, October 27, 2016 ) Publisher's, "Bcl-xL Protein Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Bcl-xL Protein Inhibitors. The Publisher's Report covers the product profiles in various...
Source: EmailWire.com
 (Medical-NewsWire.com, October 27, 2016 ) Publisher's, "Autophagy modulators-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Autophagy modulators. The Publisher's Report covers the product profiles in various stages of...
Source: EmailWire.com
 (Medical-NewsWire.com, October 27, 2016 ) DelveInsight's, "Anti-CD40 Antibody-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Anti-CD40 Antibody. The DelveInsight's Report covers the product profiles in various stages of...
Source: EmailWire.com
 (Medical-NewsWire.com, October 27, 2016 ) Publisher's, "AMPK Beta Activators-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the AMPK Beta Activators. The Publisher's Report covers the product profiles in various stages of...
Source: EmailWire.com
 (Medical-NewsWire.com, October 27, 2016 ) Publisher's, "AMP Activated Protein Kinase (AMPK) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the AMP Activated Protein Kinase (AMPK) Inhibitors. The Publisher's Report...
Source: EmailWire.com
 (Medical-NewsWire.com, October 27, 2016 ) Publisher's, "Aggrecanase Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Aggrecanase Inhibitors. The Publisher's Report covers the product profiles in various stages...
Source: EmailWire.com
 (Medical-NewsWire.com, October 27, 2016 ) DelveInsight's, "50S Ribosomal Subunit (50S RNA) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the 50S Ribosomal Subunit (50S RNA) Inhibitors. The DelveInsight's Report...
Source: EmailWire.com
 (Medical-NewsWire.com, October 27, 2016 ) The patient engagement solutions market is projected to reach USD 16.39 Billion by 2020 from USD 6.68 Billion in 2015, at a CAGR of 19.7% from 2015 to 2020.Download FREE PDF Brochure@ http://www.marketsandmarkets.com/pdfdownload.asp?id=105975994Growth of...
Source: EmailWire.com
 (Medical-NewsWire.com, October 27, 2016 ) Browse 374 market data Tables and 44 Figures spread through 360 Pages and in-depth TOC on "Dental Consumables Market" rnhttp://www.marketsandmarkets.com/Market-Reports/oral-care-products-dental-consumables-market-699.htmlEarly buyers will receive 10% customization...
Source: EmailWire.com
 (Medical-NewsWire.com, October 27, 2016 ) DelveInsight's, " Nasopharyngitis (Common Cold)-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Nasopharyngitis (Common Cold). The DelveInsight'sReport covers the product profiles...
Source: EmailWire.com
 (Medical-NewsWire.com, October 27, 2016 ) DelveInsight's Report, "Severe Psoriasis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe....
Source: EmailWire.com
 (Medical-NewsWire.com, October 27, 2016 ) DelveInsight's, " Functional (Non Ulcer) Dyspepsia-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Functional (Non Ulcer) Dyspepsia. The DelveInsight'sReport covers the product...
Source: EmailWire.com
 (Medical-NewsWire.com, October 27, 2016 ) DelveInsight's, "Retinoid x receptors Gamma (RXRs) Agonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Retinoid x receptors Gamma (RXRs) Agonists. The DelveInsight's Report...
Source: EmailWire.com
 (Medical-NewsWire.com, October 27, 2016 ) DelveInsight's Report, "Angioedema-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key...
Source: EmailWire.com
|
|
|
|
